Avilar Therapeutics is based in Waltham, MA. It has raised $75M in total funding. Latest round: Seed.
Avilar Therapeutics funding overview
Avilar Therapeutics is based in Waltham, MA. Avilar Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in February 2023. The round record for Avilar Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include New Enterprise Associates, RA Capital Management, venBio Partners. 3 distinct backers are named across the disclosed rounds.
Avilar Therapeutics at a glance
Total raised
$75M
Latest round
Seed
Latest round date
February 2023
Headquarters
Waltham, MA
Notable investors
New Enterprise Associates, RA Capital Management, venBio Partners
Frequently asked about Avilar Therapeutics funding
How much has Avilar Therapeutics raised?
Avilar Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Avilar Therapeutics?
New Enterprise Associates, RA Capital Management, venBio Partners are named among the investors backing Avilar Therapeutics.
What was the latest Avilar Therapeutics funding round?
The most recent disclosed round is a Seed, announced in February 2023.
Where is Avilar Therapeutics based?
Avilar Therapeutics is based in Waltham, MA.
When did Avilar Therapeutics last raise?
The last disclosed Avilar Therapeutics round closed in February 2023 at Seed.
We update the Avilar Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.
